|
6281 |
Structure of N′-(adamantan-2-ylidene)benzohydrazide, a potential antibacterial agent, in solution: Molecular dynamics simulations, quantum chemical calculations and Ultraviolet–visible spectroscopy studies
Enthalten in Journal of chemical sciences Bd. 128, 18.10.2016, Nr. 12, date:12.2016: 1933-1942
|
|
|
|
6282 |
Structure transformations and dielectric properties of extruded and annealed polyvinylidene fluoride films
Enthalten in Iranian polymer journal Bd. 33, 20.11.2023, Nr. 1, date:1.2024: 1-10
|
|
|
|
6283 |
Struggling towards co-existence of the Baltic Sea coastal fisheries and the grey seal
Enthalten in Maritime studies Bd. 24, 6.12.2024, Nr. 1, date:3.2025: 1-15
|
|
|
|
6284 |
Studien über Beziehungen zwischen Rhodanbildung und kropfbildender Eigenschaft von Nahrungsmitteln, V. Vergleich der Wirkung von Weißkohl und Rhodanid auf die Rattenschilddrüse
Enthalten in Biological chemistry Bd. 335, 1964, Nr. Jahresband: 216-220
|
|
|
|
6285 |
Study of regioselectivity in cyanomethylation of 4-(trifluoromethyl)pyrimidin-2(1Н)-ones
Enthalten in Chemistry of heterocyclic compounds Bd. 55, 20.2.2019, Nr. 1, date:1.2019: 66-71
|
|
|
|
6286 |
Study of sorbents for analysis of radiocesium in seawater samples by one-column method
Enthalten in Journal of radioanalytical and nuclear chemistry Bd. 327, 25.1.2021, Nr. 3, date:3.2021: 1095-1103
|
|
|
|
6287 |
Study of vitamin D receptor gene polymorphisms in a cohort of myocardial infarction patients with coronary artery disease
Enthalten in BMC cardiovascular disorders Bd. 21, 16.4.2021, Nr. 1, date:12.2021: 1-9
|
|
|
|
6288 |
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Enthalten in BMC cancer Bd. 15, 14.3.2015, Nr. 1, date:12.2015: 1-10
|
|
|
|
6289 |
Study protocol: the Norwegian Triple-S Cohort Study - establishing a longitudinal health survey of children and adolescents with experiences of maltreatment
Enthalten in BMC public health Bd. 21, 5.6.2021, Nr. 1, date:12.2021: 1-10
|
|
|
|
6290 |
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Enthalten in Targeted oncology Bd. 18, 2.9.2023, Nr. 5, date:9.2023: 639-641
|
|
Administration
